| Todd Joseph Duellman, MD | |
|
140 24th St S, Wisconsin Rapids, WI 54494-1906 | |
| (715) 424-1881 | |
| (715) 423-1602 |
| Full Name | Todd Joseph Duellman |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 18 Years |
| Location | 140 24th St S, Wisconsin Rapids, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467493296 | NPI | - | NPPES |
| 34866900 | Medicaid | WI | |
| P00346189 | Other | WI | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 125-042504 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspirus Riverview Hospital & Clinics Inc | Wisconsin rapids, WI | Hospital |
| Marshfield Medical Center | Marshfield, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wisconsin River Orthopaedics, Ltd. | 4880607431 | 16 |
News Archive
Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, Bess Dawson-Hughes, MD, director of the Bone Metabolism Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses.
A new study summarizes over 30 years of clinical experience in the treatment and management of glutaric acidemia type 1 (GA1), a rare and potentially devastating metabolic disorder caused by variants in the GCDH gene.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 6 days ago
| Entity Name | Wisconsin River Orthopaedics, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144274390 PECOS PAC ID: 4880607431 Enrollment ID: O20060726000232 |
News Archive
Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, Bess Dawson-Hughes, MD, director of the Bone Metabolism Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses.
A new study summarizes over 30 years of clinical experience in the treatment and management of glutaric acidemia type 1 (GA1), a rare and potentially devastating metabolic disorder caused by variants in the GCDH gene.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Joseph Duellman, MD Po Box 8005, Wisconsin Rapids, WI 54495-8005 Ph: (715) 424-1881 | Todd Joseph Duellman, MD 140 24th St S, Wisconsin Rapids, WI 54494-1906 Ph: (715) 424-1881 |
News Archive
Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, Bess Dawson-Hughes, MD, director of the Bone Metabolism Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
A study in Molecular Oncology indicates that examining the protein and RNA in leftover materials from routine diagnostic tests for breast cancer may lead to more accurate diagnoses.
A new study summarizes over 30 years of clinical experience in the treatment and management of glutaric acidemia type 1 (GA1), a rare and potentially devastating metabolic disorder caused by variants in the GCDH gene.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 6 days ago
James Wilkes, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 140 24th St S, Wisconsin Rapids, WI 54494 Phone: 715-424-1881 Fax: 715-423-1602 | |
Douglas Galuk, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 24th St S, Wisconsin Rapids, WI 54494 Phone: 715-424-1881 Fax: 715-423-1602 | |
Dr. John W Mcdonough Ii, DO Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 410 Dewey St, Wisconsin Rapids, WI 54495 Phone: 715-421-5257 |